tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HALO Stock Latest News

Buy Rating for Halozyme: Strong Growth Prospects Backed by Successful MajesTEC-3 Trial and Robust Financial Valuation
RatingsBuy Rating for Halozyme: Strong Growth Prospects Backed by Successful MajesTEC-3 Trial and Robust Financial Valuation
2d ago
HALO
Halozyme price target lowered to $79 from $80 at Morgan Stanley
PremiumThe Fly
Halozyme price target lowered to $79 from $80 at Morgan Stanley
3d ago
HALO
Halozyme’s Strong Royalty Revenue and Strategic Initiatives Justify Buy Rating Despite Potential Risks
PremiumRatings
Halozyme’s Strong Royalty Revenue and Strategic Initiatives Justify Buy Rating Despite Potential Risks
3d ago
HALO
Halozyme’s Strong Financial Outlook and Strategic Investment Potential Amidst Policy Stability
PremiumRatings
Halozyme’s Strong Financial Outlook and Strategic Investment Potential Amidst Policy Stability
8d ago
HALO
Halozyme upgraded at Leerink on lower-than-feared Part B exposure
PremiumThe Fly
Halozyme upgraded at Leerink on lower-than-feared Part B exposure
9d ago
HALO
Halozyme upgraded to Market Perform from Underperform at Leerink
PremiumThe FlyHalozyme upgraded to Market Perform from Underperform at Leerink
9d ago
HALO
Halozyme Confirms Minimal Impact from Medicare Guidance
Premium
Company Announcements
Halozyme Confirms Minimal Impact from Medicare Guidance
9d ago
8K
HALO
Halozyme Appoints New Chief Operating Officer
Premium
Company Announcements
Halozyme Appoints New Chief Operating Officer
17d ago
8K
HALO
Halozyme names Cortney Caudill as COO
PremiumThe Fly
Halozyme names Cortney Caudill as COO
17d ago
HALO
Halozyme Announces Merger Agreement with Elektrofi
PremiumCompany Announcements
Halozyme Announces Merger Agreement with Elektrofi
20d ago
8K
HALO
Halozyme’s Strategic Expansion and Financial Growth: Buy Rating Affirmed
PremiumRatings
Halozyme’s Strategic Expansion and Financial Growth: Buy Rating Affirmed
21d ago
HALO
Halozyme price target raised to $90 from $85 at H.C. Wainwright
PremiumThe Fly
Halozyme price target raised to $90 from $85 at H.C. Wainwright
21d ago
HALO
Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
PremiumThe FlyNike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
22d ago
F
AES
Halozyme Acquires Elektrofi to Enhance Drug Delivery
Premium
Company Announcements
Halozyme Acquires Elektrofi to Enhance Drug Delivery
22d ago
8K
HALO
Halozyme backs FY25 adjusted EPS view $6.00-$6.40, consensus $6.05
Premium
The Fly
Halozyme backs FY25 adjusted EPS view $6.00-$6.40, consensus $6.05
22d ago
HALO
Halozyme sees Elektrofi deal less than 5% dilutive to EPS over medium term
PremiumThe Fly
Halozyme sees Elektrofi deal less than 5% dilutive to EPS over medium term
22d ago
HALO
Halozyme to acquire Elektrofi for upfront payment of $750M
PremiumThe Fly
Halozyme to acquire Elektrofi for upfront payment of $750M
22d ago
HALO
Halozyme price target raised to $90 from $75 at Benchmark
PremiumThe Fly
Halozyme price target raised to $90 from $75 at Benchmark
29d ago
MRK
HALO
Halozyme’s Strong Financial Performance and Strategic Positioning Justify Buy Rating Amid Patent Challenges
PremiumRatings
Halozyme’s Strong Financial Performance and Strategic Positioning Justify Buy Rating Amid Patent Challenges
29d ago
HALO
Halozyme price target raised to $85 from $75 at H.C. Wainwright
PremiumThe FlyHalozyme price target raised to $85 from $75 at H.C. Wainwright
1M ago
HALO
Halozyme price target raised to $80 from $75 at Morgan Stanley
Premium
The Fly
Halozyme price target raised to $80 from $75 at Morgan Stanley
2M ago
HALO
Halozyme’s Strong Financial Performance and Growth Potential Justifies Buy Rating
Premium
Ratings
Halozyme’s Strong Financial Performance and Growth Potential Justifies Buy Rating
2M ago
HALO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >